Skip to main content
Caplight Logo









LENZ Therapeutics

LENZ Therapeutics

Public
Solana Beach, CaliforniaHealthcarewww.lenz-tx.com

LENZ Therapeutics is now publicly traded

The data on this page reflects LENZ Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

PIPE

Jul 15, 2024

Total Funding Raised

$214M

Company Overview

LENZ Therapeutics (NAS: LENZ) is a biopharmaceutical company dedicated to developing and commercializing innovative therapies aimed at enhancing vision, with a primary focus on treating presbyopia, a common age-related decline in near vision affecting individuals over 45.

Sector

Healthcare

AI Layer

Non-AI

Keywords

aceclidine-based eye drop for presbyopiaVIZZ (aceclidine ophthalmic solution)FDA-approved presbyopia treatmentonce-daily presbyopia eye droptreatment for age-related blurry near visionpupil-selective mioticpinhole effect eye dropnon-invasive reading glasses alternativepreservative-free ophthalmic solutionophthalmic drug commercializationinternational pharmaceutical licensing

LENZ Therapeutics Comparables

Compare LENZ Therapeutics with similar companies based on industry and business-model similarity.

LENZ Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

LENZ Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
PIPEJul 15, 2024
PIPEMar 21, 2024
Series BMar 7, 2023
Series AJun 17, 2021

Key People

Founding team and executive leadership

Eef Schimmelpennink

President and CEO

Executive Team

LENZ Therapeutics Investors

Notable investors and investment history

LENZ Therapeutics investors
InvestorRounds
RA Capital ManagementSeries A, Series B, PIPE
Ridgeback CapitalPIPE
Versant VenturesSeries A, Series B, PIPE
SectoralSeries B
RTW InvestmentsPIPE, Series B
Samsara BioCapitalPIPE
Alpha Wave GlobalSeries B, PIPE

LENZ Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LENZ Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSolana Beach, California
Employee Range160
Year Founded2021
Last FundingJul 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?